Cancer Immunotherapy Market to Surpass USD 264.6 Billion by 2032

Jul, 2024 Consumer Goods

Cancer Immunotherapy Market Growth Opportunities and Forecast till 2032

Category by- Consumer Goods , No. of Pages - 250, Published By - Ameco Research

CHAPTER 1. Dosage Overview of Cancer Immunotherapy Market
1.1. Definition and Scope
1.1.1. Definition of Cancer Immunotherapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cancer Immunotherapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cancer Immunotherapy Market By Product
1.2.3. Cancer Immunotherapy Market By Application
1.2.4. Cancer Immunotherapy Market By End-User
1.2.5. Cancer Immunotherapy Market By Regions

CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data End-Use
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cancer Immunotherapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cancer Immunotherapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2022
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Cancer Immunotherapy By Product
4.1. Introduction
4.2. Cancer Immunotherapy Revenue By Product
4.2.1. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast, By Product, 2020-2032
4.2.2. Monoclonal Antibodies
4.2.2.1. Monoclonal Antibodies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.3. Immunomodulators
4.2.3.1. Immunomodulators Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.4. Oncolytic Viral Therapies & Cancer Vaccines
4.2.4.1. Oncolytic Viral Therapies & Cancer Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 5. Cancer Immunotherapy By Application
5.1. Introduction
5.2. Cancer Immunotherapy Revenue By Application
5.2.1. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast, By Application, 2020-2032
5.2.2. Lung Cancer
5.2.2.1. Lung Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Breast Cancer
5.2.3.1. Breast Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Colorectal Cancer
5.2.4.1. Colorectal Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Melanoma
5.2.5.1. Melanoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Prostate Cancer
5.2.6.1. Prostate Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. Head & Neck Cancer
5.2.7.1. Head & Neck Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.8. Ovarian Cancer
5.2.8.1. Ovarian Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.9. Pancreatic Cancer
5.2.9.1. Pancreatic Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.10. Others
5.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Cancer Immunotherapy By End-User
6.1. Introduction
6.2. Cancer Immunotherapy Revenue By End-User
6.2.1. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast, By End-User, 2020-2032
6.2.2. Hospitals & Clinics
6.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Cancer Research Centers
6.2.3.1. Cancer Research Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. North America Cancer Immunotherapy Market By Country
7.1. North America Cancer Immunotherapy Market Overview
7.2. U.S.
7.2.1. U.S. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
7.2.2. U.S. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
7.2.3. U.S. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
7.3. Canada
7.3.1. Canada Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
7.3.2. Canada Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
7.3.3. Canada Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
7.4. North America PEST Analysis

CHAPTER 8. Europe Cancer Immunotherapy Market By Country
8.1. Europe Cancer Immunotherapy Market Overview
8.2. U.K.
8.2.1. U.K. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.2.2. U.K. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.2.3. U.K. Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.3. Germany
8.3.1. Germany Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3.2. Germany Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.3.3. Germany Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.4. France
8.4.1. France Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.4.2. France Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.4.3. France Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.5. Spain
8.5.1. Spain Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.5.2. Spain Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.5.3. Spain Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
8.6.2. Rest of Europe Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
8.6.3. Rest of Europe Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Cancer Immunotherapy Market By Country
9.1. Asia Pacific Cancer Immunotherapy Market Overview
9.2. China
9.2.1. China Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. China Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.3. China Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Japan
9.3.1. Japan Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Japan Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.3. Japan Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. India
9.4.1. India Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4.2. India Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.4.3. India Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.5. Australia
9.5.1. Australia Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5.2. Australia Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.5.3. Australia Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.6. South Korea
9.6.1. South Korea Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6.2. South Korea Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.6.3. South Korea Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
9.7.2. Rest of Asia-Pacific Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.7.3. Rest of Asia-Pacific Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Cancer Immunotherapy Market By Country
10.1. Latin America Cancer Immunotherapy Market Overview
10.2. Brazil
10.2.1. Brazil Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. Brazil Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.3. Brazil Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Mexico
10.3.1. Mexico Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Mexico Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.3. Mexico Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. Rest of Latin America Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.3. Rest of Latin America Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Cancer Immunotherapy Market By Country
11.1. Middle East & Africa Cancer Immunotherapy Market Overview
11.2. GCC
11.2.1. GCC Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. GCC Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.3. GCC Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. South Africa
11.3.1. South Africa Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. South Africa Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.3. South Africa Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. Rest of Middle East & Africa Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.3. Rest of Middle East & Africa Cancer Immunotherapy Market Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Cancer Immunotherapy
12.1. Cancer Immunotherapy Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Cancer Immunotherapy Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. COMPANY PROFILE
13.1. AstraZeneca
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. AstraZeneca 2022 Cancer Immunotherapy Business Regional Distribution
13.1.4. Product / Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Bristol-Myers Squibb Company
13.3. F. Hoffmann-La Roche Ltd.
13.4. Immunocore, Ltd.
13.5. Janssen Global Services, LLC
13.6. Johnson & Johnson Services, Inc.
13.7. Lilly
13.8. Merck & Co. Inc.
13.9. Novartis AG
13.10. Pfizer Inc.

Quick Buy

Request Sample Check Discount Enquiry Before Buying